NCT05556980Completed
Totally Laparoscopic Distal Gastrectomy for Gastric Cancer
Randomized Controlled Trial Comparing the Outcomes of Totally Laparoscopic Distal Gastrectomy and Laparoscopy-assisted Gastrectomy for Gastric Cancer
Source: ClinicalTrials.gov · Last updated 25 Sept 2024
Brief summary (registry, in English)
This study was designed as a randomized clinical trial comparing the totally laparoscopic distal gastrectomy with laparoscopy-assisted distal gastroectomy for patients with gastric cancer, in terms of short-term and long-term outcomes.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 120 (actual)
- First submitted
- 18 Sept 2022
- Start date
- 1 Sept 2021
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Liu Liu
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT05556980
What you commit to
- Study type: Interventional
- Participants enrolled: 120
- From 1 Sept 2021 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- patients with total or proximal gastrectomy;
- patients with distant metastasis.
Who the study is looking for
- aged 18-80 years old, no gender limitation;
- primary gastric cancer and planed for distal gastrectomy;
Age in the registry: 18 years to 80 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xubing Zhang Coordinator of this site? Confirm its status | Hefei | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.